Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD
Clinical trial NCT03335852 · COMPLETED
Trial details
- NCT number
- NCT03335852
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2018-10-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.